{"nct_id":"NCT06764186","title":"A Phase IIIB Study to Evaluate the Use of Capivasertib in Combination With Fulvestrant in Patients With Advanced Breast Cancer Who Have Relapsed/Progressed on ET and CDK4/6 Inhibitor Reflecting Real World Clinical Practice in Spain","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2025-01-07","start_date_type":"ACTUAL","primary_completion_date":"2027-12-31","primary_completion_date_type":"ESTIMATED","completion_date":"2027-12-31","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}